We fight Low-Grade Chronic Inflammation, the major cause of premature deaths globally*
We are the first company to fight Low-Grade Chronic Inflammation
— “the Secret Killer” — through an anti-inflammaging® ecosystem powered by a digital platform, which will strengthen the immune system, prevent diseases and premature aging, and will even help to contrast Covid-19*.
From rare to everywhere
2001
Rare diseases
Our long journey started in 2001 with Mondobiotech, a Swiss-based biotechnology company focused on developing human peptides as therapies for patients affected by rare diseases. This experience led to the creation of a first team of experts. Over the years, our research expanded to the field of genetics and the pinpointing of genetic factors, which can influence the performance, health and aging of the body.
2015
2018
The secret killer
In 2018, specific studies on
low-grade chronic inflammation began: we understood the strong relation between LCGI, inflammation-related diseases (cancer, heart diseases, Alzheimer’s, …) and premature ageing. We discovered that the best and safest way to lower LGCI is with anti-inflammatory behaviours in nutrition, ambient, cognition and movement.
2020
The Anti-Inflammaging Company
2020 sees the launch of The Anti-Inflammaging Company: a large, global research facility, which aims to fight inflammation-related diseases by outlining healthier lifestyles with which to strengthen immune defences.
2022
Epam Systems
We selected EPAM Systems Inc (NYSE: EPAM) as our technical provider. A leading worldwide technology company at the top of global IT Services ranking lists, to develop a smart and reliable platform, capable of bridging clients’ needs with global science, ranging from cockpits to apps and any other digital device.
This means reliable and guaranteed scalability, allowing us to reach anywhere in the world.
Some of EPAM’s clients:
"We serve a diverse and global list of clients across 11 industries, from more than 50 countries. Our clients are some of the world’s leading corporations, with 62 of our top 100 clients in the Fortune 500 or Forbes Global 2000."
2023
Effe Perfect Wellness
Effegibi, leading company in the sector of wellness products, namely saunas and hammams, has engaged The Anti-Inflammaging Company for the realization of a scientific report analyzing the impact of Heat Therapy on health with particular reference to low-grade chronic inflammation. After the validation by our scientific community, the findings from this report were converted into tailored content (profiling questions and tips), through the Digital Platform, available to the Client in the form of APIs.
Meet the Founders
Management
Board
Advisory Board
